Role of advanced oxidation protein products and Thiol ratio in patients with acute coronary syndromes

Clinical Biochemistry

Volumn 44, Issue 8-9, 2011, Pages 605-611

  Barsotti, Antonio ^a   Fabbi, Patrizia ^a   Fedele, Massimiliano ^a   Garibaldi, Silvano ^a   Balbi, Manrico ^a   Bezante, Gian Paolo ^a   Risso, Domenico ^b   Indiveri, Francesco ^a   Ghigliotti, Giorgio ^a   Brunelli, Claudio ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Acute coronary syndromes; AOPP; Inflammation; Oxidative stress; OxLDL; Thiols

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT; C REACTIVE PROTEIN; INTERLEUKIN 1BETA; THIOL;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MALE; PRIORITY JOURNAL; UNSTABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; AGED; ANGINA, UNSTABLE; BLOOD PROTEINS; C-REACTIVE PROTEIN; CHOLESTEROL; CHOLESTEROL, HDL; FEMALE; HUMANS; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SULFHYDRYL COMPOUNDS; TRIGLYCERIDES;

EID: 79955791157     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2011.03.134     Document Type: Article

References (49)

1. Holvoet P., Vanhaecke J., Janssens S., Van de Werf F., Collen D. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation 1998, 98:1487-1494.
2. Fabbi P., Ghigliotti G., Brunelli C., Balbi M., Spallarossa P., Rossettin P., et al. Intense lipid peroxidation in premature clinical coronary atherosclerosis is associated with metabolic abnormalities. J Lab Clin Med 2004, 143:99-105.
3. Libby P., Ridker P.M., Maseri A. Inflammation and atherosclerosis. Circulation 2002, 105:1135-1143.
4. Serneri G.G., Abbate R., Gori A.M., Attanasio M., Martini F., Giusti B., et al. Transient intermittent lymphocyte activation is responsible for the instability of angina. Circulation 1992, 86:790-797.
5. Hoeschen R.J. Oxidative stress and cardiovascular disease. Can J Cardiol 1997, 13:1021-1025.
6. Bittner A., Alcaíno H., Castro P.F., Pérez O., Corbalán R., Troncoso R., et al. Matrix metalloproteinase-9 activity is associated to oxidative stress in patients with acute coronary syndrome. Int J Cardiol 2010, 143:98-100.
7. Leeuwenburgh C., Hardy M.M., Hazen S.L., Wagner P., Oh-ishi S., Steinbrecher U.P., et al. Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima. J Biol Chem 1997, 17:1433-1436.
8. Dubois-Randé J.L., Artigou J.Y., Darmon J.Y., Habbal R., Manuel C., Tayarani I., et al. Oxidative stress in patients with unstable angina. Eur Heart J 1994, 15:179-183.
9. Holvoet P., Collen D. Oxidation of low density lipoproteins in the pathogenesis of atherosclerosis. Atherosclerosis 1998, 137:S33-38.
10. Kaneda H., Taguchi J., Ogasawara K., Aizawa T., Ohno M. Increased level of advanced oxidation protein products in patients with coronary artery disease. Atherosclerosis 2002, 162:221-225.
11. Tamer L., Sucu N., Polat G., Ercan B., Aytacoglu B., Yücebilgiç G., et al. Decreased serum total antioxidant status and erythrocyte-reduced glutathione levels are associated with increased serum malondialdehyde in atherosclerotic patients. Arch Med Res 2002, 33:257-260.
12. Dogru-Abbasoglu S., Kanbagli O., Bulur H., Babalik E., Oztürk S., Aykaç-Toker G., et al. Lipid peroxides and antioxidant status in serum of patients with angiographically defined coronary atherosclerosis. Clin Biochem 1999, 32:671-672.
13. Ferrari R., Ceconi C., Curello S., Cargnoni A., Alfieri O., Pardini A., et al. Oxygen free radicals and myocardial damage: protective role of thiol-containing agents. Am J Med 1991, 91:95S-105S.
14. Traverso N., Menini S., Cottalasso D., Odetti P., Marinari U.M., Pronzato M.A. Mutual interaction between glycation and oxidation during non-enzymatic protein modification. Biochim Biophys Acta 1997, 1336:409-418.
15. Pandey K.B., Mehdi M.M., Maurya P.K., Rizvi S.I. Plasma protein oxidation and its correlation with antioxidant potential during human aging. Dis Markers 2010, 29:31-36.
16. Kondo T., Hirose M., Kageyama K. Roles of oxidative stress and redox regulation in atherosclerosis. J Atheroscler Thromb 2009, 16:532-538.
17. Witko-Sarsat V., Friedlander M., Nguyen Khoa T., Capeillère-Blandin C., Nguyen A.T., Canteloup S., et al. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol 1998, 161:2524-2532.
18. Skvarilová M., Bulava A., Stejskal D., Adamovská S., Bartek J. Increased level of advanced oxidation products (AOPP) as a marker of oxidative stress in patients with acute coronary syndrome. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2005, 149:83-87.
19. Alderman C.J., Shah S., Foreman J.C., Chain B.M., Katz D.R. The role of advanced oxidation protein products in regulation of dendritic cell function. Free Radic Biol Med 2002, 32:377-385.
20. Descamps-Latscha B., Witko-Sarsat V., Nguyen-Khoa T., Nguyen A.T., Gausson V., Mothu N., et al. Advanced oxidation protein products as risk factors for atherosclerotic cardiovascular events in nondiabetic predialysis patients. Am J Kidney Dis 2005, 45:39-47.
21. Liuzzo G., Biasucci L.M., Gallimore J.R., Grillo R.L., Rebuzzi A.G., Pepys M.B., et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 1994, 331:417-424.
22. Lindhal B., Toss H., Siegbahn A., Venge P., Wallentin L. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. N Engl J Med 2000, 343:1139-1147.
23. Maresi E., Midulla R., Cospite V., Morici N., Tavormina R., Fazio G., et al. Transmural coronary inflammation triggers simultaneous multivessel rupture of unstable plaques. Ital Heart J 2003, 4:488-491.
24. Witko-Sarsat V., Friedlander M., Capeillère-Blandin C., Nguyen-Khoa T., Nguyen A.T., Zingraff J., et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996, 49:1304-1313.
25. Sedlak J., Lindsay R.H. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem 1968, 25:192-205.
26. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
27. Siegel S., Castellan N.J. Nonparametric statistics for the behavioral sciences 1988, McGraw-Hill, NewYork. second ed.
28. Spallarossa P., Garibaldi S., Barisione C., Ghigliotti G., Altieri P., Tracchi I., et al. Postprandial serum induces apoptosis in endothelial cells: role of polymorphonuclear-derived myeloperoxidase and metalloproteinase-9 activity. Atherosclerosis 2008, 198:458-467.
29. Baldus S., Heeschen C., Meinertz T., Zeiher A.M., Eiserich J.P., Münzel T., et al. CAPTURE investigators, myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 2003, 108:1440-1445.
30. Heinecke J.W., Li W., Daehnke H.L., Goldstein J.A. Dityrosine, a specific marker of oxidation, is synthesized by the myeloperoxidase-hydrogen peroxide system of human neutrophils and macrophages. J Biol Chem 1993, 268:4069-4077.
31. Cakatay U., Kayali R., Uzun H. Relation of plasma protein oxidation parameters and paraoxonase activity in the ageing population. Clin Exp Med 2008, 8:51-57.
32. Rizvi S.I., Maurya P.K. Alterations in antioxidant enzymes during aging in humans. Mol Biotechnol 2007, 37:58-61.
33. Gornik O., Lauc G. Glycosylation of serum proteins in inflammatory diseases. Dis Markers 2008, 25:267-278.
34. Samiec P.S., Drews-Botsch C., Flagg E.W., Kurtz J.C., Jr Sternberg P., Reed R.L., et al. Glutathione in human plasma: decline in association with aging, age-related macular degeneration, and diabetes. Free Radic Biol Med 1998, 24:699-704.
35. Iciek M., Chwatko G., Lorenc-Koci E., Bald E., Włodek L. Plasma levels of total, free and protein bound thiols as well as sulfane sulfur in different age groups of rats. Acta Biochim Pol 2004, 51:815-824.
36. Liu S.X., Hou F.F., Guo Z.J., Nagai R., Zhang W.R., Liu Z.Q., et al. Advanced oxidation protein products accelerate atherosclerosis through promotion of oxidative stress and inflammation. Arterioscler Thromb Vasc Biol 2006, 26:1156-1162.
37. Descamps-Latscha B., Witko-Sarsat V. Importance of oxidatively modified proteins in chronic renal failure. Kidney Int Suppl 2001, 78:108-113.
38. Erren M., Reinecke H., Junker R., Fobker M., Schulte H., Schurek J.O., et al. Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries. Arterioscler Thromb Vasc Biol 1999, 19:2355-2363.
39. Dinarello C.A. Biologic basis for interleukin-1 in disease. Blood 1996, 87:2095-2147.
40. Patti G., D'Ambrosio A., Dobrina A., Dicuonzo G., Giansante C., Fiotti N., et al. Interleukin-1 receptor antagonist: a sensitive marker of instability in patients with coronary artery disease. J Thromb Thrombolysis 2002, 14:139-143.
41. Nian M., Lee P., Khaper N., Liu P. Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res 2004, 94:1543-1553.
42. Deten A., Volz H.C., Briest W., Zimmer H.G. Cardiac cytokine expression is upregulated in the acute phase after myocardial infarction. Experimental studies in rats. Cardiovasc Res 2002, 55:329-340.
43. Ono K., Matsumori A., Shioi T., Furukawa Y., Sasayama S. Cytokine gene expression after myocardial infarction in rat hearts: possible implication in left ventricular remodeling. Circulation 1998, 98:149-156.
44. Malmberg K., Norhammar A., Wedel H., Rydén L. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 1999, 99:2626-2632.
45. Hewinson J., Moore S.F., Glover C., Watts A.G., MacKenzie A.B. A key role for redox signaling in rapid P2X7 receptor-induced IL-1 β processing in human monocytes. J Immunol 2008, 180:8410-8420.
46. Tassi S., Carta S., Vené R., Delfino L., Ciriolo M.R., Rubartelli A. Pathogen-induced interleukin-1beta processing and secretion is regulated by a biphasic redox response. J Immunol 2009, 183:1456-1462.
47. Merlini P.A., Bauer K.A., Oltrona L., Ardissino D., Cattaneo M., Belli C., et al. Persistent activation of coagulation mechanism in unstable angina and myocardial infarction. Circulation 1994, 90:61-68.
48. Stamler J., Mendelsohn M.E., Amarante P., Smick D., Andon N., Davies P.F., et al. N-acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factor. Circ Res 1989, 65:789-795.
49. Ky B., Burke A., Tsimikas S., Wolfe M.L., Tadesse M.G., Szapary P.O., et al. The influence of pravastatin and atorvastatin on markers of oxidative stress in hypercholesterolemic humans. J Am Coll Cardiol 2008, 51:1653-1662.